BendaMustine Hydrochloride
Bendamustine hydrochloride monotherapy or combination therapy has been designated by European and American clinical guidelines as a first - or second-line treatment option for a variety of hematological malignancies
| Supplier | CD Formulation |
|---|---|
| Product # | PAP-0094 |
| CAS # | 631-540-0 |
| Pricing | , Inquire for price |
| Solubility | H2O: >30mg/mL |
| product1 | Other Active Pharmaceutical Ingredients |
| Storage | room temp |
| Molecular Formula | C16H22Cl3N3O2 |
| Applications | Treatment of Chronic Lymphocytic Leukemia (CLL) |
| Melting Point | 149-151°C |
| Molecular Weight (g/mol) | 394.72 |
| CAS Number | 3543-75-7 |
| Appearance | Powder |
| Color | off-white |
| Physical State | powder |